ID   TNKS2_HUMAN             Reviewed;        1166 AA.
AC   Q9H2K2; B2RBD3; Q9H8F2; Q9HAS4;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   10-MAY-2017, entry version 168.
DE   RecName: Full=Tankyrase-2;
DE            Short=TANK2;
DE            EC=2.4.2.30;
DE   AltName: Full=ADP-ribosyltransferase diphtheria toxin-like 6;
DE            Short=ARTD6;
DE   AltName: Full=Poly [ADP-ribose] polymerase 5B;
DE   AltName: Full=TNKS-2;
DE   AltName: Full=TRF1-interacting ankyrin-related ADP-ribose polymerase 2;
DE   AltName: Full=Tankyrase II;
DE   AltName: Full=Tankyrase-like protein;
DE   AltName: Full=Tankyrase-related protein;
GN   Name=TNKS2; Synonyms=PARP5B, TANK2, TNKL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RX   PubMed=11205898;
RA   Monz D., Munnia A., Comtesse N., Fischer U., Steudel W.-I., Feiden W.,
RA   Glass B., Meese E.U.;
RT   "Novel tankyrase-related gene detected with meningioma-specific
RT   sera.";
RL   Clin. Cancer Res. 7:113-119(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Mammary carcinoma;
RX   PubMed=11294570; DOI=10.1038/sj.gene.6363722;
RA   Kuimov A.N., Kuprash D.V., Petrov V.N., Vdovichenko K.K.,
RA   Scanlan M.J., Jongeneel C.V., Lagarkova M.A., Nedospasov S.A.;
RT   "Cloning and characterization of TNKL, a member of tankyrase gene
RT   family.";
RL   Genes Immun. 2:52-55(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RC   TISSUE=Liver;
RX   PubMed=11278563; DOI=10.1074/jbc.M009756200;
RA   Lyons R.J., Deane R., Lynch D.K., Ye Z.-S.J., Sanderson G.M.,
RA   Eyre H.J., Sutherland G.R., Daly R.J.;
RT   "Identification of a novel human tankyrase through its interaction
RT   with the adaptor protein Grb14.";
RL   J. Biol. Chem. 276:17172-17180(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RC   TISSUE=Placenta;
RX   PubMed=11454873; DOI=10.1074/jbc.M105968200;
RA   Kaminker P.G., Kim S.-H., Taylor R.D., Zebarjadian Y., Funk W.D.,
RA   Morin G.B., Yaswen P., Campisi J.;
RT   "TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes
RT   rapid induction of cell death upon overexpression.";
RL   J. Biol. Chem. 276:35891-35899(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INTERACTION WITH TRF1 AND
RP   LNPEP/OTASE.
RC   TISSUE=Skeletal muscle;
RX   PubMed=11802774; DOI=10.1042/0264-6021:3610451;
RA   Sbodio J.I., Lodish H.F., Chi N.-W.;
RT   "Tankyrase-2 oligomerizes with tankyrase-1 and binds to both TRF1
RT   (telomere-repeat-binding factor 1) and IRAP (insulin-responsive
RT   aminopeptidase).";
RL   Biochem. J. 361:451-459(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Yin Y., Gelmann E.P.;
RL   Submitted (OCT-2001) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [9]
RP   FUNCTION, AND ADP-RIBOSYLATION.
RX   PubMed=11739745; DOI=10.1128/MCB.22.1.332-342.2002;
RA   Cook B.D., Dynek J.N., Chang W., Shostak G., Smith S.;
RT   "Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2
RT   at human telomeres.";
RL   Mol. Cell. Biol. 22:332-342(2002).
RN   [10]
RP   INTERACTION WITH HIF1AN, AND HYDROXYLATION AT ASN-203; ASN-271;
RP   ASN-427; ASN-518; ASN-586; ASN-671; ASN-706 AND ASN-739.
RX   PubMed=18936059; DOI=10.1074/mcp.M800340-MCP200;
RA   Cockman M.E., Webb J.D., Kramer H.B., Kessler B.M., Ratcliffe P.J.;
RT   "Proteomics-based identification of novel factor inhibiting hypoxia-
RT   inducible factor (FIH) substrates indicates widespread asparaginyl
RT   hydroxylation of ankyrin repeat domain-containing proteins.";
RL   Mol. Cell. Proteomics 8:535-546(2009).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, INTERACTION WITH
RP   AXIN1 AND AXIN2, AND MUTAGENESIS OF MET-1054.
RX   PubMed=19759537; DOI=10.1038/nature08356;
RA   Huang S.M., Mishina Y.M., Liu S., Cheung A., Stegmeier F.,
RA   Michaud G.A., Charlat O., Wiellette E., Zhang Y., Wiessner S.,
RA   Hild M., Shi X., Wilson C.J., Mickanin C., Myer V., Fazal A.,
RA   Tomlinson R., Serluca F., Shao W., Cheng H., Shultz M., Rau C.,
RA   Schirle M., Schlegl J., Ghidelli S., Fawell S., Lu C., Curtis D.,
RA   Kirschner M.W., Lengauer C., Finan P.M., Tallarico J.A.,
RA   Bouwmeester T., Porter J.A., Bauer A., Cong F.;
RT   "Tankyrase inhibition stabilizes axin and antagonizes Wnt
RT   signalling.";
RL   Nature 461:614-620(2009).
RN   [12]
RP   NOMENCLATURE.
RX   PubMed=20106667; DOI=10.1016/j.tibs.2009.12.003;
RA   Hottiger M.O., Hassa P.O., Luscher B., Schuler H., Koch-Nolte F.;
RT   "Toward a unified nomenclature for mammalian ADP-
RT   ribosyltransferases.";
RL   Trends Biochem. Sci. 35:208-219(2010).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH AXIN1; AXIN2; BLZF1 AND
RP   CASC3, AND UBIQUITINATION.
RX   PubMed=21478859; DOI=10.1038/ncb2222;
RA   Zhang Y., Liu S., Mickanin C., Feng Y., Charlat O., Michaud G.A.,
RA   Schirle M., Shi X., Hild M., Bauer A., Myer V.E., Finan P.M.,
RA   Porter J.A., Huang S.M., Cong F.;
RT   "RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin
RT   degradation and Wnt signalling.";
RL   Nat. Cell Biol. 13:623-629(2011).
RN   [14]
RP   INTERACTION WITH RNF146, UBIQUITINATION, AND SUBCELLULAR LOCATION.
RX   PubMed=21799911; DOI=10.1371/journal.pone.0022595;
RA   Callow M.G., Tran H., Phu L., Lau T., Lee J., Sandoval W.N., Liu P.S.,
RA   Bheddah S., Tao J., Lill J.R., Hongo J.A., Davis D., Kirkpatrick D.S.,
RA   Polakis P., Costa M.;
RT   "Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt
RT   signaling.";
RL   PLoS ONE 6:E22595-E22595(2011).
RN   [15]
RP   FUNCTION.
RX   PubMed=23622245; DOI=10.1016/j.cell.2013.03.040;
RA   Cho-Park P.F., Steller H.;
RT   "Proteasome regulation by ADP-ribosylation.";
RL   Cell 153:614-627(2013).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.28 ANGSTROMS) OF 538-558 IN COMPLEX WITH
RP   HIF1AN; IRON AND 2-OXOGLUTARATE, HYDROXYLATION AT HIS-238 AND HIS-553,
RP   AND MUTAGENESIS OF HIS-553.
RX   PubMed=21251231; DOI=10.1111/j.1742-4658.2011.08022.x;
RA   Yang M., Chowdhury R., Ge W., Hamed R.B., McDonough M.A.,
RA   Claridge T.D., Kessler B.M., Cockman M.E., Ratcliffe P.J.,
RA   Schofield C.J.;
RT   "Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-
RT   translational hydroxylation of histidinyl residues within ankyrin
RT   repeat domains.";
RL   FEBS J. 278:1086-1097(2011).
CC   -!- FUNCTION: Poly-ADP-ribosyltransferase involved in various
CC       processes such as Wnt signaling pathway, telomere length and
CC       vesicle trafficking. Acts as an activator of the Wnt signaling
CC       pathway by mediating poly-ADP-ribosylation of AXIN1 and AXIN2, 2
CC       key components of the beta-catenin destruction complex: poly-ADP-
CC       ribosylated target proteins are recognized by RNF146, which
CC       mediates their ubiquitination and subsequent degradation. Also
CC       mediates poly-ADP-ribosylation of BLZF1 and CASC3, followed by
CC       recruitment of RNF146 and subsequent ubiquitination. Mediates
CC       poly-ADP-ribosylation of TERF1, thereby contributing to the
CC       regulation of telomere length. May also regulate vesicle
CC       trafficking and modulate the subcellular distribution of
CC       SLC2A4/GLUT4-vesicles. Stimulates 26S proteasome activity.
CC       {ECO:0000269|PubMed:11739745, ECO:0000269|PubMed:11802774,
CC       ECO:0000269|PubMed:19759537, ECO:0000269|PubMed:21478859,
CC       ECO:0000269|PubMed:23622245}.
CC   -!- CATALYTIC ACTIVITY: NAD(+) + (ADP-D-ribosyl)(n)-acceptor =
CC       nicotinamide + (ADP-D-ribosyl)(n+1)-acceptor.
CC       {ECO:0000255|PROSITE-ProRule:PRU00397,
CC       ECO:0000269|PubMed:19759537, ECO:0000269|PubMed:21478859}.
CC   -!- ENZYME REGULATION: Specifically inhibited by XAV939, a small
CC       molecule, leading to inhibit the Wnt signaling pathway by
CC       stabilizing AXIN1 and AXIN2. {ECO:0000269|PubMed:19759537}.
CC   -!- SUBUNIT: Oligomerizes and associates with TNKS. Interacts with the
CC       cytoplasmic domain of LNPEP/Otase in SLC2A4/GLUT4-vesicles. Binds
CC       to the N-terminus of Grb14 and TRF1 with its ankyrin repeat
CC       region. Interacts with HIF1AN. Interacts with RNF146; this
CC       interaction leads to ubiquitination and proteasomal degradation.
CC       {ECO:0000269|PubMed:11802774, ECO:0000269|PubMed:18936059,
CC       ECO:0000269|PubMed:19759537, ECO:0000269|PubMed:21251231,
CC       ECO:0000269|PubMed:21478859, ECO:0000269|PubMed:21799911}.
CC   -!- INTERACTION:
CC       O15084:ANKRD28; NbExp=3; IntAct=EBI-4398527, EBI-359567;
CC       O15169:AXIN1; NbExp=2; IntAct=EBI-4398527, EBI-710484;
CC       Q9NWV8:BABAM1; NbExp=4; IntAct=EBI-4398527, EBI-745725;
CC       P11274:BCR; NbExp=3; IntAct=EBI-4398527, EBI-712838;
CC       Q6V0I7:FAT4; NbExp=2; IntAct=EBI-4398527, EBI-948985;
CC       Q9NWT6:HIF1AN; NbExp=4; IntAct=EBI-4398527, EBI-745632;
CC       Q92698:RAD54L; NbExp=3; IntAct=EBI-4398527, EBI-5333483;
CC       P78314:SH3BP2; NbExp=5; IntAct=EBI-4398527, EBI-727062;
CC       Q06649:Sh3bp2 (xeno); NbExp=6; IntAct=EBI-4398527, EBI-5323518;
CC       O43815:STRN; NbExp=2; IntAct=EBI-4398527, EBI-1046642;
CC       P54274:TERF1; NbExp=2; IntAct=EBI-4398527, EBI-710997;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Golgi apparatus membrane;
CC       Peripheral membrane protein. Nucleus. Chromosome, telomere
CC       {ECO:0000305}. Note=Associated with the Golgi and with
CC       juxtanuclear SLC2A4/GLUT4-vesicles. Also found around the
CC       pericentriolar matrix of mitotic centromeres. During interphase, a
CC       small fraction of TNKS2 is found in the nucleus, associated with
CC       TRF1.
CC   -!- TISSUE SPECIFICITY: Highly expressed in placenta, skeletal muscle,
CC       liver, brain, kidney, heart, thymus, spinal cord, lung, peripheral
CC       blood leukocytes, pancreas, lymph nodes, spleen, prostate, testis,
CC       ovary, small intestine, colon, mammary gland, breast and breast
CC       carcinoma, and in common-type meningioma. Highly expressed in
CC       fetal liver, heart and brain.
CC   -!- PTM: Ubiquitinated at 'Lys-48' and 'Lys-63' by RNF146 when auto-
CC       poly-ADP-ribosylated; this leads to degradation.
CC   -!- PTM: ADP-ribosylated (-auto). Poly-ADP-ribosylated protein is
CC       recognized by RNF146, followed by ubiquitination.
CC   -!- PTM: The crystallographic evidence suggests that the 3-
CC       hydroxyhistidine may be the (3S) stereoisomer.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG25674.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAB14665.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF305081; AAG25674.1; ALT_INIT; mRNA.
DR   EMBL; AF264912; AAG44694.1; -; mRNA.
DR   EMBL; AF329696; AAK13463.1; -; mRNA.
DR   EMBL; AF342982; AAK25811.1; -; mRNA.
DR   EMBL; AF309033; AAK82330.1; -; mRNA.
DR   EMBL; AF438201; AAL40795.1; -; mRNA.
DR   EMBL; AK023746; BAB14665.1; ALT_INIT; mRNA.
DR   EMBL; AK314612; BAG37180.1; -; mRNA.
DR   EMBL; AL359707; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS7417.1; -.
DR   RefSeq; NP_079511.1; NM_025235.3.
DR   UniGene; Hs.329327; -.
DR   PDB; 2Y0I; X-ray; 2.28 A; S=538-558.
DR   PDB; 3KR7; X-ray; 1.95 A; A=946-1162.
DR   PDB; 3KR8; X-ray; 2.10 A; A/C=946-1162.
DR   PDB; 3MHJ; X-ray; 1.80 A; A/B=946-1162.
DR   PDB; 3MHK; X-ray; 2.30 A; A=952-1166.
DR   PDB; 3P0N; X-ray; 1.90 A; A/C=946-1162.
DR   PDB; 3P0P; X-ray; 2.49 A; A/C=946-1162.
DR   PDB; 3P0Q; X-ray; 1.90 A; A/C=946-1162.
DR   PDB; 3TWQ; X-ray; 2.15 A; A/B=484-655.
DR   PDB; 3TWR; X-ray; 1.55 A; A/B/C/D=488-649.
DR   PDB; 3TWS; X-ray; 1.70 A; A/B/C/D=488-649.
DR   PDB; 3TWT; X-ray; 1.85 A; A/B/C/D=488-649.
DR   PDB; 3TWU; X-ray; 1.80 A; A=488-649.
DR   PDB; 3TWV; X-ray; 2.30 A; A/B/C/D=488-649.
DR   PDB; 3TWW; X-ray; 2.00 A; A/B=488-649.
DR   PDB; 3TWX; X-ray; 1.80 A; A/B=488-649.
DR   PDB; 3U9H; X-ray; 1.75 A; A/B=946-1162.
DR   PDB; 3U9Y; X-ray; 2.30 A; A=946-1162.
DR   PDB; 3UA9; X-ray; 2.15 A; A/B=946-1162.
DR   PDB; 3W51; X-ray; 2.00 A; A/B=952-1161.
DR   PDB; 4AVU; X-ray; 2.40 A; A/B=946-1162.
DR   PDB; 4AVW; X-ray; 2.15 A; A/B=946-1162.
DR   PDB; 4BFP; X-ray; 2.40 A; A/B=946-1162.
DR   PDB; 4BJ9; X-ray; 2.05 A; A/B=946-1162.
DR   PDB; 4BJB; X-ray; 2.30 A; A=946-1162.
DR   PDB; 4BJC; X-ray; 2.20 A; A=946-1162.
DR   PDB; 4BS4; X-ray; 1.89 A; A/B=946-1162.
DR   PDB; 4BU3; X-ray; 2.15 A; A/B=946-1162.
DR   PDB; 4BU5; X-ray; 1.80 A; A/B=946-1162.
DR   PDB; 4BU6; X-ray; 1.80 A; A/B=946-1162.
DR   PDB; 4BU7; X-ray; 2.05 A; A/C=946-1162.
DR   PDB; 4BU8; X-ray; 1.85 A; A/C=946-1162.
DR   PDB; 4BU9; X-ray; 1.65 A; A/B=946-1162.
DR   PDB; 4BUA; X-ray; 1.85 A; A/C=946-1162.
DR   PDB; 4BUD; X-ray; 2.50 A; A/C=946-1162.
DR   PDB; 4BUE; X-ray; 1.60 A; A/B=946-1162.
DR   PDB; 4BUF; X-ray; 2.50 A; A/B=946-1162.
DR   PDB; 4BUI; X-ray; 1.95 A; A/C=946-1162.
DR   PDB; 4BUS; X-ray; 1.90 A; A/B=946-1162.
DR   PDB; 4BUT; X-ray; 1.90 A; A/B=946-1162.
DR   PDB; 4BUU; X-ray; 1.60 A; A/B=946-1162.
DR   PDB; 4BUV; X-ray; 1.80 A; A/C=946-1162.
DR   PDB; 4BUW; X-ray; 1.85 A; A/B=946-1162.
DR   PDB; 4BUX; X-ray; 1.95 A; A/C=946-1162.
DR   PDB; 4BUY; X-ray; 1.90 A; A/B=946-1162.
DR   PDB; 4HKI; X-ray; 2.15 A; A/H=946-1113, C/D=1114-1162.
DR   PDB; 4HKK; X-ray; 1.95 A; A/C=946-1113, B/D=1114-1162.
DR   PDB; 4HKN; X-ray; 2.05 A; A=946-1113, C=1114-1162.
DR   PDB; 4HL5; X-ray; 2.20 A; A=946-1113, C=1114-1162.
DR   PDB; 4HLF; X-ray; 2.15 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4HLG; X-ray; 2.00 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4HLH; X-ray; 1.75 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4HLK; X-ray; 2.00 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4HLM; X-ray; 1.95 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4HMH; X-ray; 2.30 A; A=946-1113, C=1114-1162.
DR   PDB; 4HYF; X-ray; 2.80 A; A/B/C=946-1162.
DR   PDB; 4IUE; X-ray; 2.38 A; A=952-1161.
DR   PDB; 4J1Z; X-ray; 2.00 A; A/B=952-1161.
DR   PDB; 4J21; X-ray; 1.93 A; A=952-1161.
DR   PDB; 4J22; X-ray; 2.12 A; A/B=952-1161.
DR   PDB; 4J3L; X-ray; 2.09 A; A=952-1161.
DR   PDB; 4J3M; X-ray; 1.90 A; A/B=952-1161.
DR   PDB; 4KZL; X-ray; 2.00 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4KZQ; X-ray; 2.25 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4KZU; X-ray; 2.10 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4L09; X-ray; 2.05 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4L0B; X-ray; 1.80 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4L0I; X-ray; 2.30 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4L0S; X-ray; 1.90 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4L0T; X-ray; 2.10 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4L0V; X-ray; 1.70 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4L10; X-ray; 1.70 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4L2F; X-ray; 2.05 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4L2G; X-ray; 2.05 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4L2K; X-ray; 2.10 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4L31; X-ray; 2.00 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4L32; X-ray; 1.85 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4L33; X-ray; 2.10 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4L34; X-ray; 1.80 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 4M7B; X-ray; 1.95 A; A/C=946-1162.
DR   PDB; 4PML; X-ray; 1.87 A; A/B/C/D=959-1164.
DR   PDB; 4PNL; X-ray; 1.50 A; A/B/C/D=959-1164.
DR   PDB; 4PNM; X-ray; 2.19 A; A/B/C/D=959-1164.
DR   PDB; 4PNN; X-ray; 1.65 A; A/B/C/D=959-1164.
DR   PDB; 4PNQ; X-ray; 1.85 A; A/B/C/D=959-1164.
DR   PDB; 4PNR; X-ray; 1.71 A; A/B/C/D=959-1164.
DR   PDB; 4PNS; X-ray; 1.65 A; A/B/C/D=959-1164.
DR   PDB; 4PNT; X-ray; 1.60 A; A/B/C/D=959-1164.
DR   PDB; 4TJU; X-ray; 1.57 A; A/B/C/D=959-1164.
DR   PDB; 4TJW; X-ray; 1.70 A; A/B/C/D=959-1164.
DR   PDB; 4TJY; X-ray; 1.90 A; A/B/C/D=959-1164.
DR   PDB; 4TK0; X-ray; 1.65 A; A/B/C/D=959-1164.
DR   PDB; 4TK5; X-ray; 2.02 A; A/B/C/D=959-1164.
DR   PDB; 4TKF; X-ray; 2.60 A; A/B/C/D=959-1164.
DR   PDB; 4TKG; X-ray; 1.95 A; A/B/C/D=959-1164.
DR   PDB; 4TKI; X-ray; 2.15 A; A/B/C/D=959-1164.
DR   PDB; 4UFU; X-ray; 2.10 A; A/B=946-1162.
DR   PDB; 4UFY; X-ray; 1.70 A; A/B=946-1162.
DR   PDB; 4UHG; X-ray; 1.70 A; A/B=946-1162.
DR   PDB; 4UI3; X-ray; 2.00 A; A/B=946-1113, C/D=1115-1162.
DR   PDB; 4UI4; X-ray; 2.40 A; A/B=946-1113, C/D=1115-1162.
DR   PDB; 4UI5; X-ray; 1.65 A; A/B=946-1113, C/D=1115-1162.
DR   PDB; 4UI6; X-ray; 1.80 A; A/B=946-1113, C/D=1115-1162.
DR   PDB; 4UI7; X-ray; 1.80 A; A/B=946-1113, C/D=1115-1162.
DR   PDB; 4UI8; X-ray; 2.05 A; A/B=946-1113, C/D=1115-1162.
DR   PDB; 4UVL; X-ray; 2.00 A; A/C=946-1162.
DR   PDB; 4UVN; X-ray; 2.20 A; A/B=946-1162.
DR   PDB; 4UVO; X-ray; 1.85 A; A/B=946-1162.
DR   PDB; 4UVP; X-ray; 1.75 A; A/C=946-1113, B/D=1115-1162.
DR   PDB; 4UVS; X-ray; 2.00 A; A/C=946-1162.
DR   PDB; 4UVT; X-ray; 1.95 A; A/C=946-1162.
DR   PDB; 4UVU; X-ray; 1.95 A; A/B=946-1162.
DR   PDB; 4UVV; X-ray; 1.90 A; A/B=946-1162.
DR   PDB; 4UVW; X-ray; 2.10 A; A/B=946-1162.
DR   PDB; 4UVX; X-ray; 1.95 A; A/B=946-1162.
DR   PDB; 4UVY; X-ray; 1.95 A; A/B=946-1162.
DR   PDB; 4UVZ; X-ray; 1.60 A; A/C=946-1162.
DR   PDB; 4UX4; X-ray; 1.80 A; A/B=946-1162.
DR   PDB; 4W5I; X-ray; 1.95 A; A/B=952-1162.
DR   PDB; 4Z68; X-ray; 1.86 A; A=490-644.
DR   PDB; 5ADQ; X-ray; 2.10 A; A=946-1113, B=1115-1162.
DR   PDB; 5ADR; X-ray; 2.10 A; A=946-1113, B=1115-1162.
DR   PDB; 5ADS; X-ray; 1.80 A; A=946-1113, B=1115-1162.
DR   PDB; 5ADT; X-ray; 2.15 A; A=946-1113, B=1115-1162.
DR   PDB; 5AEH; X-ray; 1.85 A; A/B=946-1162.
DR   PDB; 5AKU; X-ray; 1.80 A; A/B=946-1162.
DR   PDB; 5AKW; X-ray; 2.07 A; A/B=946-1162.
DR   PDB; 5AL1; X-ray; 1.75 A; A/B=946-1162.
DR   PDB; 5AL2; X-ray; 1.90 A; A/B=946-1162.
DR   PDB; 5AL3; X-ray; 1.75 A; A/B=946-1162.
DR   PDB; 5AL4; X-ray; 1.90 A; A/B=946-1162.
DR   PDB; 5AL5; X-ray; 2.05 A; A/B=946-1162.
DR   PDB; 5BXO; X-ray; 1.33 A; A/B=488-649.
DR   PDB; 5BXU; X-ray; 1.35 A; A=488-649.
DR   PDB; 5C5P; X-ray; 1.75 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 5C5Q; X-ray; 2.00 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 5C5R; X-ray; 1.55 A; A/B=946-1113, C/D=1114-1162.
DR   PDB; 5DCZ; X-ray; 2.23 A; A=936-1166.
DR   PDB; 5FPF; X-ray; 2.60 A; A/B=946-1113, C/D=1115-1162.
DR   PDB; 5FPG; X-ray; 2.75 A; A/B=946-1162.
DR   PDB; 5JRT; X-ray; 1.53 A; A=867-940.
DR   PDBsum; 2Y0I; -.
DR   PDBsum; 3KR7; -.
DR   PDBsum; 3KR8; -.
DR   PDBsum; 3MHJ; -.
DR   PDBsum; 3MHK; -.
DR   PDBsum; 3P0N; -.
DR   PDBsum; 3P0P; -.
DR   PDBsum; 3P0Q; -.
DR   PDBsum; 3TWQ; -.
DR   PDBsum; 3TWR; -.
DR   PDBsum; 3TWS; -.
DR   PDBsum; 3TWT; -.
DR   PDBsum; 3TWU; -.
DR   PDBsum; 3TWV; -.
DR   PDBsum; 3TWW; -.
DR   PDBsum; 3TWX; -.
DR   PDBsum; 3U9H; -.
DR   PDBsum; 3U9Y; -.
DR   PDBsum; 3UA9; -.
DR   PDBsum; 3W51; -.
DR   PDBsum; 4AVU; -.
DR   PDBsum; 4AVW; -.
DR   PDBsum; 4BFP; -.
DR   PDBsum; 4BJ9; -.
DR   PDBsum; 4BJB; -.
DR   PDBsum; 4BJC; -.
DR   PDBsum; 4BS4; -.
DR   PDBsum; 4BU3; -.
DR   PDBsum; 4BU5; -.
DR   PDBsum; 4BU6; -.
DR   PDBsum; 4BU7; -.
DR   PDBsum; 4BU8; -.
DR   PDBsum; 4BU9; -.
DR   PDBsum; 4BUA; -.
DR   PDBsum; 4BUD; -.
DR   PDBsum; 4BUE; -.
DR   PDBsum; 4BUF; -.
DR   PDBsum; 4BUI; -.
DR   PDBsum; 4BUS; -.
DR   PDBsum; 4BUT; -.
DR   PDBsum; 4BUU; -.
DR   PDBsum; 4BUV; -.
DR   PDBsum; 4BUW; -.
DR   PDBsum; 4BUX; -.
DR   PDBsum; 4BUY; -.
DR   PDBsum; 4HKI; -.
DR   PDBsum; 4HKK; -.
DR   PDBsum; 4HKN; -.
DR   PDBsum; 4HL5; -.
DR   PDBsum; 4HLF; -.
DR   PDBsum; 4HLG; -.
DR   PDBsum; 4HLH; -.
DR   PDBsum; 4HLK; -.
DR   PDBsum; 4HLM; -.
DR   PDBsum; 4HMH; -.
DR   PDBsum; 4HYF; -.
DR   PDBsum; 4IUE; -.
DR   PDBsum; 4J1Z; -.
DR   PDBsum; 4J21; -.
DR   PDBsum; 4J22; -.
DR   PDBsum; 4J3L; -.
DR   PDBsum; 4J3M; -.
DR   PDBsum; 4KZL; -.
DR   PDBsum; 4KZQ; -.
DR   PDBsum; 4KZU; -.
DR   PDBsum; 4L09; -.
DR   PDBsum; 4L0B; -.
DR   PDBsum; 4L0I; -.
DR   PDBsum; 4L0S; -.
DR   PDBsum; 4L0T; -.
DR   PDBsum; 4L0V; -.
DR   PDBsum; 4L10; -.
DR   PDBsum; 4L2F; -.
DR   PDBsum; 4L2G; -.
DR   PDBsum; 4L2K; -.
DR   PDBsum; 4L31; -.
DR   PDBsum; 4L32; -.
DR   PDBsum; 4L33; -.
DR   PDBsum; 4L34; -.
DR   PDBsum; 4M7B; -.
DR   PDBsum; 4PML; -.
DR   PDBsum; 4PNL; -.
DR   PDBsum; 4PNM; -.
DR   PDBsum; 4PNN; -.
DR   PDBsum; 4PNQ; -.
DR   PDBsum; 4PNR; -.
DR   PDBsum; 4PNS; -.
DR   PDBsum; 4PNT; -.
DR   PDBsum; 4TJU; -.
DR   PDBsum; 4TJW; -.
DR   PDBsum; 4TJY; -.
DR   PDBsum; 4TK0; -.
DR   PDBsum; 4TK5; -.
DR   PDBsum; 4TKF; -.
DR   PDBsum; 4TKG; -.
DR   PDBsum; 4TKI; -.
DR   PDBsum; 4UFU; -.
DR   PDBsum; 4UFY; -.
DR   PDBsum; 4UHG; -.
DR   PDBsum; 4UI3; -.
DR   PDBsum; 4UI4; -.
DR   PDBsum; 4UI5; -.
DR   PDBsum; 4UI6; -.
DR   PDBsum; 4UI7; -.
DR   PDBsum; 4UI8; -.
DR   PDBsum; 4UVL; -.
DR   PDBsum; 4UVN; -.
DR   PDBsum; 4UVO; -.
DR   PDBsum; 4UVP; -.
DR   PDBsum; 4UVS; -.
DR   PDBsum; 4UVT; -.
DR   PDBsum; 4UVU; -.
DR   PDBsum; 4UVV; -.
DR   PDBsum; 4UVW; -.
DR   PDBsum; 4UVX; -.
DR   PDBsum; 4UVY; -.
DR   PDBsum; 4UVZ; -.
DR   PDBsum; 4UX4; -.
DR   PDBsum; 4W5I; -.
DR   PDBsum; 4Z68; -.
DR   PDBsum; 5ADQ; -.
DR   PDBsum; 5ADR; -.
DR   PDBsum; 5ADS; -.
DR   PDBsum; 5ADT; -.
DR   PDBsum; 5AEH; -.
DR   PDBsum; 5AKU; -.
DR   PDBsum; 5AKW; -.
DR   PDBsum; 5AL1; -.
DR   PDBsum; 5AL2; -.
DR   PDBsum; 5AL3; -.
DR   PDBsum; 5AL4; -.
DR   PDBsum; 5AL5; -.
DR   PDBsum; 5BXO; -.
DR   PDBsum; 5BXU; -.
DR   PDBsum; 5C5P; -.
DR   PDBsum; 5C5Q; -.
DR   PDBsum; 5C5R; -.
DR   PDBsum; 5DCZ; -.
DR   PDBsum; 5FPF; -.
DR   PDBsum; 5FPG; -.
DR   PDBsum; 5JRT; -.
DR   ProteinModelPortal; Q9H2K2; -.
DR   SMR; Q9H2K2; -.
DR   BioGrid; 123257; 27.
DR   DIP; DIP-42098N; -.
DR   IntAct; Q9H2K2; 33.
DR   MINT; MINT-1183420; -.
DR   STRING; 9606.ENSP00000360689; -.
DR   BindingDB; Q9H2K2; -.
DR   ChEMBL; CHEMBL6154; -.
DR   iPTMnet; Q9H2K2; -.
DR   PhosphoSitePlus; Q9H2K2; -.
DR   BioMuta; TNKS2; -.
DR   DMDM; 20140805; -.
DR   EPD; Q9H2K2; -.
DR   MaxQB; Q9H2K2; -.
DR   PaxDb; Q9H2K2; -.
DR   PeptideAtlas; Q9H2K2; -.
DR   PRIDE; Q9H2K2; -.
DR   DNASU; 80351; -.
DR   Ensembl; ENST00000371627; ENSP00000360689; ENSG00000107854.
DR   GeneID; 80351; -.
DR   KEGG; hsa:80351; -.
DR   UCSC; uc001khp.4; human.
DR   CTD; 80351; -.
DR   DisGeNET; 80351; -.
DR   GeneCards; TNKS2; -.
DR   HGNC; HGNC:15677; TNKS2.
DR   HPA; HPA036606; -.
DR   MIM; 607128; gene.
DR   neXtProt; NX_Q9H2K2; -.
DR   OpenTargets; ENSG00000107854; -.
DR   PharmGKB; PA38019; -.
DR   eggNOG; KOG4177; Eukaryota.
DR   eggNOG; COG0666; LUCA.
DR   GeneTree; ENSGT00840000129677; -.
DR   HOGENOM; HOG000246964; -.
DR   HOVERGEN; HBG059472; -.
DR   InParanoid; Q9H2K2; -.
DR   KO; K10799; -.
DR   OMA; LSSGCDP; -.
DR   OrthoDB; EOG091G00W8; -.
DR   PhylomeDB; Q9H2K2; -.
DR   TreeFam; TF326036; -.
DR   Reactome; R-HSA-201681; TCF dependent signaling in response to WNT.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-5545619; XAV939 inhibits tankyrase, stabilizing AXIN.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   SIGNOR; Q9H2K2; -.
DR   ChiTaRS; TNKS2; human.
DR   EvolutionaryTrace; Q9H2K2; -.
DR   GeneWiki; TNKS2; -.
DR   GenomeRNAi; 80351; -.
DR   PRO; PR:Q9H2K2; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000107854; -.
DR   CleanEx; HS_TNKS2; -.
DR   Genevisible; Q9H2K2; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; IC:BHF-UCL.
DR   GO; GO:0005635; C:nuclear envelope; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0000242; C:pericentriolar material; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:1904357; P:negative regulation of telomere maintenance via telomere lengthening; IMP:BHF-UCL.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:1904355; P:positive regulation of telomere capping; IDA:BHF-UCL.
DR   GO; GO:0032212; P:positive regulation of telomere maintenance via telomerase; IC:BHF-UCL.
DR   GO; GO:0006471; P:protein ADP-ribosylation; IDA:BHF-UCL.
DR   GO; GO:0070213; P:protein auto-ADP-ribosylation; IDA:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0070198; P:protein localization to chromosome, telomeric region; IMP:BHF-UCL.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0016055; P:Wnt signaling pathway; TAS:Reactome.
DR   Gene3D; 1.25.40.20; -; 10.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR012317; Poly(ADP-ribose)pol_cat_dom.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 5.
DR   Pfam; PF00644; PARP; 1.
DR   Pfam; PF07647; SAM_2; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 15.
DR   SMART; SM00454; SAM; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF48403; SSF48403; 4.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 15.
DR   PROSITE; PS51059; PARP_CATALYTIC; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; ANK repeat; Chromosome;
KW   Complete proteome; Cytoplasm; Glycosyltransferase; Golgi apparatus;
KW   Hydroxylation; Membrane; Metal-binding; NAD; Nucleus;
KW   Reference proteome; Repeat; Telomere; Transferase; Ubl conjugation;
KW   Wnt signaling pathway; Zinc.
FT   CHAIN         1   1166       Tankyrase-2.
FT                                /FTId=PRO_0000211334.
FT   REPEAT       57     89       ANK 1.
FT   REPEAT       90    122       ANK 2.
FT   REPEAT      123    155       ANK 3.
FT   REPEAT      210    242       ANK 4.
FT   REPEAT      243    275       ANK 5.
FT   REPEAT      276    308       ANK 6.
FT   REPEAT      363    398       ANK 7.
FT   REPEAT      399    431       ANK 8.
FT   REPEAT      432    464       ANK 9.
FT   REPEAT      525    557       ANK 10.
FT   REPEAT      558    590       ANK 11.
FT   REPEAT      591    623       ANK 12.
FT   REPEAT      678    710       ANK 13.
FT   REPEAT      711    743       ANK 14.
FT   REPEAT      744    776       ANK 15.
FT   DOMAIN      873    936       SAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00184}.
FT   DOMAIN      959   1164       PARP catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00397}.
FT   REGION      545    553       HIF1AN-binding.
FT   METAL      1081   1081       Zinc. {ECO:0000250|UniProtKB:O95271}.
FT   METAL      1084   1084       Zinc. {ECO:0000250|UniProtKB:O95271}.
FT   METAL      1089   1089       Zinc. {ECO:0000250|UniProtKB:O95271}.
FT   METAL      1092   1092       Zinc. {ECO:0000250|UniProtKB:O95271}.
FT   MOD_RES     203    203       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:18936059}.
FT   MOD_RES     238    238       (3S)-3-hydroxyhistidine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:21251231}.
FT   MOD_RES     271    271       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:18936059}.
FT   MOD_RES     427    427       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:18936059}.
FT   MOD_RES     518    518       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:18936059}.
FT   MOD_RES     553    553       (3S)-3-hydroxyhistidine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:21251231}.
FT   MOD_RES     586    586       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:18936059}.
FT   MOD_RES     671    671       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:18936059}.
FT   MOD_RES     706    706       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:18936059}.
FT   MOD_RES     739    739       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:18936059}.
FT   MUTAGEN     553    553       H->D: Enhanced hydroxylation by HIF1AN.
FT                                {ECO:0000269|PubMed:21251231}.
FT   MUTAGEN     553    553       H->N: Enhanced hydroxylation by HIF1AN.
FT                                {ECO:0000269|PubMed:21251231}.
FT   MUTAGEN    1054   1054       M->V: Loss of activity.
FT                                {ECO:0000269|PubMed:19759537}.
FT   CONFLICT    115    115       A -> T (in Ref. 7; BAG37180).
FT                                {ECO:0000305}.
FT   CONFLICT    331    337       KGHSLLQ -> QRPLVAA (in Ref. 1; AAG25674).
FT                                {ECO:0000305}.
FT   CONFLICT    357    361       NFKHP -> IQAS (in Ref. 1; AAG25674).
FT                                {ECO:0000305}.
FT   CONFLICT    966    966       Q -> P (in Ref. 7; BAB14665).
FT                                {ECO:0000305}.
FT   HELIX       488    502       {ECO:0000244|PDB:5BXO}.
FT   HELIX       505    511       {ECO:0000244|PDB:5BXO}.
FT   TURN        514    518       {ECO:0000244|PDB:5BXO}.
FT   TURN        522    525       {ECO:0000244|PDB:5BXO}.
FT   HELIX       529    535       {ECO:0000244|PDB:5BXO}.
FT   HELIX       539    547       {ECO:0000244|PDB:5BXO}.
FT   HELIX       562    568       {ECO:0000244|PDB:5BXO}.
FT   HELIX       572    580       {ECO:0000244|PDB:5BXO}.
FT   HELIX       595    602       {ECO:0000244|PDB:5BXO}.
FT   HELIX       605    613       {ECO:0000244|PDB:5BXO}.
FT   HELIX       628    631       {ECO:0000244|PDB:5BXO}.
FT   HELIX       637    644       {ECO:0000244|PDB:5BXO}.
FT   HELIX       876    884       {ECO:0000244|PDB:5JRT}.
FT   HELIX       888    890       {ECO:0000244|PDB:5JRT}.
FT   HELIX       891    896       {ECO:0000244|PDB:5JRT}.
FT   HELIX       901    904       {ECO:0000244|PDB:5JRT}.
FT   HELIX       909    914       {ECO:0000244|PDB:5JRT}.
FT   HELIX       920    936       {ECO:0000244|PDB:5JRT}.
FT   STRAND      954    957       {ECO:0000244|PDB:5C5R}.
FT   HELIX       964    974       {ECO:0000244|PDB:4PNL}.
FT   TURN        980    986       {ECO:0000244|PDB:4PNL}.
FT   STRAND      990    999       {ECO:0000244|PDB:4PNL}.
FT   HELIX      1003   1018       {ECO:0000244|PDB:4PNL}.
FT   TURN       1019   1021       {ECO:0000244|PDB:4PNL}.
FT   STRAND     1026   1031       {ECO:0000244|PDB:4PNL}.
FT   HELIX      1036   1042       {ECO:0000244|PDB:4PNL}.
FT   HELIX      1046   1048       {ECO:0000244|PDB:4PNL}.
FT   TURN       1053   1055       {ECO:0000244|PDB:4TJW}.
FT   STRAND     1059   1064       {ECO:0000244|PDB:4PNL}.
FT   HELIX      1065   1069       {ECO:0000244|PDB:4PNL}.
FT   TURN       1070   1073       {ECO:0000244|PDB:4PNL}.
FT   HELIX      1075   1077       {ECO:0000244|PDB:4PNL}.
FT   TURN       1082   1084       {ECO:0000244|PDB:4PNL}.
FT   STRAND     1090   1092       {ECO:0000244|PDB:4PNL}.
FT   STRAND     1094   1102       {ECO:0000244|PDB:4PNL}.
FT   STRAND     1105   1109       {ECO:0000244|PDB:4PNL}.
FT   STRAND     1115   1117       {ECO:0000244|PDB:4PNL}.
FT   STRAND     1123   1127       {ECO:0000244|PDB:4PNL}.
FT   STRAND     1131   1133       {ECO:0000244|PDB:4PNL}.
FT   STRAND     1138   1143       {ECO:0000244|PDB:4PNL}.
FT   HELIX      1144   1146       {ECO:0000244|PDB:4PNL}.
FT   STRAND     1147   1157       {ECO:0000244|PDB:4PNL}.
SQ   SEQUENCE   1166 AA;  126918 MW;  4C8B3B8D97CEF704 CRC64;
     MSGRRCAGGG AACASAAAEA VEPAARELFE ACRNGDVERV KRLVTPEKVN SRDTAGRKST
     PLHFAAGFGR KDVVEYLLQN GANVQARDDG GLIPLHNACS FGHAEVVNLL LRHGADPNAR
     DNWNYTPLHE AAIKGKIDVC IVLLQHGAEP TIRNTDGRTA LDLADPSAKA VLTGEYKKDE
     LLESARSGNE EKMMALLTPL NVNCHASDGR KSTPLHLAAG YNRVKIVQLL LQHGADVHAK
     DKGDLVPLHN ACSYGHYEVT ELLVKHGACV NAMDLWQFTP LHEAASKNRV EVCSLLLSYG
     ADPTLLNCHN KSAIDLAPTP QLKERLAYEF KGHSLLQAAR EADVTRIKKH LSLEMVNFKH
     PQTHETALHC AAASPYPKRK QICELLLRKG ANINEKTKEF LTPLHVASEK AHNDVVEVVV
     KHEAKVNALD NLGQTSLHRA AYCGHLQTCR LLLSYGCDPN IISLQGFTAL QMGNENVQQL
     LQEGISLGNS EADRQLLEAA KAGDVETVKK LCTVQSVNCR DIEGRQSTPL HFAAGYNRVS
     VVEYLLQHGA DVHAKDKGGL VPLHNACSYG HYEVAELLVK HGAVVNVADL WKFTPLHEAA
     AKGKYEICKL LLQHGADPTK KNRDGNTPLD LVKDGDTDIQ DLLRGDAALL DAAKKGCLAR
     VKKLSSPDNV NCRDTQGRHS TPLHLAAGYN NLEVAEYLLQ HGADVNAQDK GGLIPLHNAA
     SYGHVDVAAL LIKYNACVNA TDKWAFTPLH EAAQKGRTQL CALLLAHGAD PTLKNQEGQT
     PLDLVSADDV SALLTAAMPP SALPSCYKPQ VLNGVRSPGA TADALSSGPS SPSSLSAASS
     LDNLSGSFSE LSSVVSSSGT EGASSLEKKE VPGVDFSITQ FVRNLGLEHL MDIFEREQIT
     LDVLVEMGHK ELKEIGINAY GHRHKLIKGV ERLISGQQGL NPYLTLNTSG SGTILIDLSP
     DDKEFQSVEE EMQSTVREHR DGGHAGGIFN RYNILKIQKV CNKKLWERYT HRRKEVSEEN
     HNHANERMLF HGSPFVNAII HKGFDERHAY IGGMFGAGIY FAENSSKSNQ YVYGIGGGTG
     CPVHKDRSCY ICHRQLLFCR VTLGKSFLQF SAMKMAHSPP GHHSVTGRPS VNGLALAEYV
     IYRGEQAYPE YLITYQIMRP EGMVDG
//
